bioRxiv Science⌕ Search

Biology subjects

Deshpande, A.

Publications and source records attributed to Deshpande, A..

At least 19 recordsLinked to original sources

Interpretable spherical geometry of single-cell state transitions from dominant principal components

Single-cell RNA-seq atlases are commonly explored with nonlinear embeddings that preserve neighborhoods but provide limited coordinate-level interpretation. We asked whether projecting the dominant principal components (PCs) of single-cell gene expression onto a unit sphere would yield an interpretable coordinate system. SPHERE-PCA L2-normalizes the first three PC coordinates, aligns a biologically defined root to the north pole, and represents each cell by three coordinates: root-aligned geodesic distance ({theta}), angular position ({phi}), and pre-projection radial magnitude (r). Across developmental and disease-associated datasets, this representation reveals structured spherical geometry, ranging from near-great-circle trajectories to multi-arc manifolds. In developmental atlases, root-aligned geodesic distance increases as CytoTRACE-inferred stemness decreases, while gene-coordinate analyses separate programs associated with angular position from those associated with radial magnitude. Fixed-loading perturbations decompose each gene's effect on cell position into progression, branch- or state-position, and radial activity components. SPHERE-PCA therefore provides a deterministic, loading-preserving coordinate framework for interpreting dominant transcriptomic variance and establishing a transparent geometric coordinate framework for perturbation analysis and virtual-cell models.

systems biology↗

Heterobenzamides exhibit bacteriostatic activity against intracellular Mycobacterium tuberculosis by targeting aerobic respiration

We previously identified a series of heterobenzamides (HBAs) with potent growth inhibitory activity against Mycobacterium tuberculosis in axenic culture. We also provided evidence that these target QcrB, a component of the terminal cytochrome oxidase in the electron transport chain. We expanded our studies to look at the full microbiological profile: key molecules from the series were tested for activity under different conditions and against additional strains. HBA analogs were active against intracellular bacteria where they exhibited bacteriostatic activity. A strain of M. tuberculosis with a mutation in QcrB (T313I) was resistant to HBAs in both axenic culture and inside macrophages. HBAs retained potency against lineages and mono-resistant strains of M. tuberculosis. HBAs had a narrow spectrum of activity, since they were not active against the ESKAPEE pathogens. Combination of the key HBA with bedaquiline was synergistic, as expected for a QcrB inhibitor, but there was no strong synergy with other drugs. Exposure of M. tuberculosis to the key HBA led to ATP depletion and boosted the oxygen consumption rate. This effect was specific to M. tuberculosis, since human THP-1 macrophage-like cells were unaffected by exposure to the HBA. HBA did not induce the production of reactive oxygen species or affect membrane potential but did affect pH homeostasis. Taken together, these data provide further evidence to support the identification of QcrB as the target and indicate that they are suitable for further drug development.

microbiology↗

Disrupting a Convergent Acetylation Circuit Collapses Leukemic Identity Across AML Subtypes

Transcriptional condensates anchored by chromatin readers are increasingly recognized as organizing hubs for gene expression, but how their assembly and stability are regulated remains poorly understood. Here, we identify an acetylation-dependent feed-forward circuit that controls the integrity of the Super Elongation Complex (SEC), a key driver of transcriptional elongation. We show that the SAGA histone acetyltransferase catalytic subunits KAT2A/KAT2B license acetylation of both histone H3 lysine 9 (H3K9ac) and SEC components themselves, including ENL, AFF1, and AFF3. Loss of this dual acetylation activity, achieved via a cereblon-recruiting PROTAC (GSK983/GSK699), displaces the chromatin reader ENL from target loci, dissolves ENL-anchored transcriptional condensates, and disrupts SEC-dependent transcriptional output - linking histone and non-histone acetylation to the physical integrity of a core transcriptional machine. Using genome-scale dependency data, we show that the SAGA complex is a selective chromatin dependency in acute myeloid leukemia (AML) AML and hematological malignancies and disrupting this feed-forward transcriptional circuit in AML demonstrates subtype independent antileukemia effects. KAT2A/B degradation drives potent, broad-spectrum antileukemic activity across genetically diverse AML cell lines, primary patient samples, and an isogenic KMT2A-rearranged model bearing cooperating oncogenic mutations, with H3K9ac loss concentrated asymmetrically at core AML oncogene loci such as MYC, MYB, and the HOXA cluster. Together, these findings define an acetylation-dependent circuit governing SEC integrity and establish KAT2A/B degradation as a mechanism-based, pan-AML therapeutic strategy, with implications for transcriptional condensate regulation beyond leukemia. HIGHLIGHTSO_LIThe SAGA complex is a selectively essential chromatin dependency across hematological malignancies and particularly in AML C_LIO_LIKAT2A/B degradation drives broad anti-leukemic activity across genetically diverse AML subtypes including chemo-refractory disease C_LIO_LIKAT2A/B degradation depletes H3K9ac at AML oncogene loci and dismantles ENL-anchored condensates C_LIO_LIKAT2A/B licenses regulation of super elongation complex acetylation and ENL interaction with SEC complex components C_LI

cancer biology↗

Clear cell renal cell carcinoma consensus transcriptomic programs reveal converging trajectories towards aggressive disease

Clear cell renal cell carcinoma (ccRCC) is characterized by a branching genomic trajectory in which early biallelic VHL inactivation splits into PBRM1- and BAP1-mutant lineages. However, driver mutations alone do not account for the molecular and phenotypic heterogeneity. To dissect this heterogeneity, we developed a non-negative matrix factorization (NMF)-based gene expression analytical framework for identifying recurrent transcriptional programs across factorization dimensionalities and across datasets. We applied it to three curated datasets (IMmotion151, n = 823; JAVELIN Renal 101, n = 726; TCGA, n = 614) to define 17 consensus transcriptomic programs (CTPs). Mapping CTPs onto single-cell RNAseq (scRNAseq) of human ccRCC tumors and patient-derived tumorgraft models linked these programs to their cellular sources, distinguishing RCC-intrinsic, tumor-cell-extrinsic, and mixed programs. RCC-intrinsic CTPs associated with canonical drivers, including VHL (R1), PBRM1 (R2), BAP1 (R4), PTEN/TSC1 (R3), TFE3/TFEB fusions (R5), NF2 (R6), and CDKN2A/TP53 (MP-Prolif). Additional CTPs captured tumor microenvironment (TME) composition (TME-Tcell, TME-Myelo, TME-Endo, TME-Stroma) and biological processes active across multiple cellular compartments, including proliferation, Y-chromosome-linked expression in male tumors, ciliary biology, and translation. Trajectory inference methods revealed PBRM1-like and BAP1-like branches that converged on a shared aggressive late transcriptomic stage (TS) associated with higher nuclear grade, additional driver alterations, myeloid/stromal infiltration, and poor clinical outcomes. Spatial transcriptomics (and multiregional sequencing) of paired conventional ccRCC and sarcomatoid regions linked TS advancement with morphological progression and clonal evolution. After adjusting for stage, grade, and BAP1/PBRM1 status, TS remained independently prognostic. Furthermore, our data suggest that immune checkpoint inhibitor combinations are particularly beneficial for MP-Prolif and not R1 utilizing specimens. In summary, we present an atlas of recurring transcriptomic programs in RCC and an ontological framework bridging genotype, tumor-cell-intrinsic gene expression, and microenvironment remodeling, with implications for risk stratification and treatment selection in ccRCC.

Cancer Biology↗

TAp63-regulated oncogenic long non-coding RNA-8 ( TROLL-8 ) regulates human breast cancer progression through CPT1A-mediated fatty acid oxidation

Metabolic reprogramming is a crucial hallmark of cancer, supporting tumor growth and adaptation to cellular stress. Although fatty acid oxidation (FAO) has emerged as an important regulator in cancer, the mechanisms that control the FAO machinery remain poorly understood. Here, we demonstrate that the TAp63-regulated long non-coding RNA TROLL-8 is a key regulator of FAO in breast cancer. Using metabolomics and protein microarray assays followed by immunoprecipitation-mass spectrometry, we mechanistically demonstrate that TROLL-8 binds the FAO enzyme CPT1A and promotes the formation of a complex with ACSL1 and VDAC1, thereby enabling efficient fatty acid processing. Loss of TROLL-8 destabilizes this complex, leading to impaired FAO, decreased metabolic fitness, and suppression of tumorigenic phenotypes, such as anchorage-independent growth. Notably, higher levels of CPT1A and VDAC1 are associated with worse survival in breast cancer patients. Given the emerging role of CPT1A in therapy resistance, these findings suggest that targeting TROLL-8 could be a promising approach to selectively disrupt the hyperactive FAO machinery in breast cancers and other tumor types that rely on FAO for their progression.

Cancer Biology↗

Recombinant GDF11 Improves Neurological Recovery in Models of Hemorrhagic Stroke and Traumatic Brain Injury

BackgroundIntracerebral hemorrhage (ICH) and traumatic brain injury (TBI) are leading causes of long-term neurological disability and mortality worldwide, with no approved therapies that promote functional recovery. Growth differentiation factor 11 (GDF11), a circulating TGF{beta}-family protein, has shown regenerative and neurorestorative potential in models of ischemic stroke. MethodsWe evaluated recombinant GDF11 (rGDF11) in mouse models of ICH and TBI. ICH was induced by intrastriatal collagenase injection, and neurological recovery was assessed using Neuroseverity Score (NSS), Rotarod (RR), and CatWalk (CW) analyses up to 28 days post-injury. Histological assessments of vascularization, neuronal density, and microglial/macrophage density were performed 28 days after ICH. For TBI, a closed-head injury model using a pneumatic impactor was employed, and NSS and RR assessments were conducted through 28 days post-injury. ResultsrGDF11 treatment significantly improved neurobehavioral performance following ICH, including NSS, RR, and CW parameters (forelimb base of support and average speed). Histological analyses revealed enhanced vascular area and neuronal density, with reduced microglial/macrophage density in rGDF11-treated mice. Following TBI, rGDF11 accelerated functional recovery, improving RR latency by day 6 and NSS by day 28 post-injury. ConclusionrGDF11 promotes structural and functional recovery after both hemorrhagic and traumatic brain injury in mice. These findings, together with prior evidence in ischemic stroke, support rGDF11 as a promising neurorestorative biologic with broad therapeutic potential for diverse forms of brain injury. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=178 SRC="FIGDIR/small/730114v1_ufig1.gif" ALT="Figure 1"> View larger version (30K): org.highwire.dtl.DTLVardef@8c624forg.highwire.dtl.DTLVardef@8a6107org.highwire.dtl.DTLVardef@e83ce6org.highwire.dtl.DTLVardef@f65f14_HPS_FORMAT_FIGEXP M_FIG C_FIG

neuroscience↗

UQ-PhysiCell: An extensible Python framework for uncertainty quantification and model analysis in PhysiCell

Agent-based models (ABMs) are widely used to study complex multiscale biological systems, particularly in cancer research. However, their high-dimensional parameter spaces, stochasticity, and computational costs pose significant challenges for uncertainty quantification, calibration, and systematic comparison of competing mechanistic hypotheses. PhysiCell has evolved into a growing ecosystem of open-source tools supporting physics-based multicellular modeling, including model construction, visualization, experimental data integration (e.g., spatial multiomics), and downstream output analysis. However, despite these advances, systematic support for uncertainty-aware model analysis, scalable parameter exploration, and formal calibration workflows remains limited. Here, we introduce UQ-PhysiCell, an open-source Python package that enables uncertainty quantification, calibration, and model selection for PhysiCell models using a modular and scalable workflow. UQ-PhysiCell acts as a manager of PhysiCell simulation inputs and outputs, including parameters, initial conditions, rules, and MultiCellDS-compliant objects, and provides automated orchestration of large ensembles of simulations. The framework supports multiple levels of parallelism to accelerate the analysis, including the parallel execution of independent simulations, stochastic replicates, and downstream analysis tasks. UQ-PhysiCell integrates directly with established Python libraries for sensitivity analysis, optimization, Bayesian inference, and surrogate modeling, allowing users to construct customized pipelines that match their modeling goals and computational resource requirements. UQ-PhysiCell decouples model execution from statistical analysis and emphasizes extensibility and reproducibility. This lowers the barrier to rigorous uncertainty-aware analysis and supports systematic evaluation of PhysiCell models in biological and biomedical research. Author summaryWe developed UQ-PhysiCell to address a key challenge in agent-based modeling: the systematic quantification of uncertainty in complex stochastic simulations. PhysiCell is widely used to model multicellular biological systems, particularly in cancer research; however, practical tools for uncertainty analysis, calibration, and model comparison are often developed in an ad hoc manner. This makes the results difficult to reproduce and limits the ability to rigorously evaluate competing biological hypotheses. UQ-PhysiCell provides a flexible Python framework that manages the inputs and outputs of PhysiCell simulations and enables large-scale computational analysis. We designed the software to be modular, allowing users to build their own analysis pipelines and combine different methodologies for sensitivity analysis, calibration, and model selection. Rather than enforcing a single workflow, UQ-PhysiCell supports customization to match specific scientific questions and computational requirements. To make uncertainty-aware analyses feasible for computationally intensive agent-based models, UQ-PhysiCell implements multiple parallelism strategies, enabling the concurrent execution of simulations, stochastic replicates, and downstream analyses. UQ-PhysiCell promotes reproducibility, scalability, and methodological flexibility. This helps researchers move beyond single best-fit simulations toward more reliable and interpretable computational modeling.

systems biology↗

STAPLE: automating spatial transcriptomics analysis and AI interpretation

Spatial transcriptomics workflows often span separate tools for cell typing, neighborhoods, and cell-cell communication, yielding fragmented outputs that hinder scalability, interpretation, and reproducibility. STAPLE systematizes analyses across distinct methods into a modular framework, unifying data structures and cross-tool interoperability. End-to-end analyses are performed unassisted with a single invocation, fostering rigorous, reproducible spatial transcriptomics analysis. Its novel, AI-enabled reporting layer synthesizes quantitative results into summaries of biological findings, facilitating analysis interpretation.

bioinformatics↗

A Network-Based Approach for Prioritizing Candidate Genes in Alzheimer's Disease

Alzheimers disease (AD) is a multifactorial neurodegenerative disorder characterized by coordinated dysregulation of multiple genes, requiring system-level approaches to elucidate underlying molecular mechanisms. While existing computational studies largely focus on differential expression analysis or machine-learning-based feature selection, they often overlook inter-gene relationships and network topology, limiting biological interpretability. In this study, we present a network-based framework for prioritizing candidate genes in Alzheimers disease by integrating gene co-expression network analysis with multiple centrality measures. Transcriptomic data comprising approximately 39,000 genes across 324 Alzheimers and control samples were preprocessed using log-transformation, variance filtering and Z-score normalization, followed by LASSO-based feature selection to retain phenotype-associated genes. A weighted gene co-expression network was constructed using Pearson correlation to capture coordinated transcriptional activity. Network topology was analyzed using degree, betweenness and eigenvector centrality to identify genes that are highly connected, act as information brokers or occupy influential positions within the network. A consensus ranking was derived by merging these centrality measures, enabling robust prioritization of candidate genes. The results highlight a subset of highly central genes, including several small nucleolar RNAs and regulatory transcripts implicated in RNA processing, synaptic function and neurodegenerative pathways. By jointly leveraging co-expression structure and complementary centrality metrics, the proposed framework provides an interpretable and reproducible strategy for identifying biologically meaningful gene candidates, offering potential utility for biomarker discovery and therapeutic target prioritization in Alzheimers disease.

systems biology↗

SUMO mediates the coordinate regulation of meiotic chromosome length and crossover rate

Meiotic prophase-I chromosomes are organized into linear arrays of chromatin loops anchored to proteinaceous axes that define the interaction interfaces for the pairing and synapsis of homologous chromosomes. Chromatin loop size and axial chromosome length are inversely correlated and vary widely both between and within species, including between the sexes. The molecular basis of this variation remains unclear. Here, we provide evidence that the small ubiquitin-like modifier, SUMO, regulates loop-axis organization in mouse meiosis. Our analysis shows that the longer axes of oocyte chromosomes contain more SUMO per unit length than the shorter axes of spermatocyte chromosomes. In mouse models, the loss of SUMO1 results in shorter axes and longer chromatin loops. Conversely, increased SUMO1 conjugation, caused by mutation of the SENP1 isopeptidase, produces longer axes with shorter loops. Axis length positively correlates with meiotic recombination. Accordingly, Sumo1 and Senp1 mutations respectively decrease and increase crossover frequency. These findings identify SUMO as a key regulator of meiotic chromosome architecture and suggest a molecular basis for the physiological variation in chromosome length and recombination rates seen among species, sexes, individuals, and individual meiocytes. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=101 SRC="FIGDIR/small/710713v1_ufig1.gif" ALT="Figure 1"> View larger version (31K): org.highwire.dtl.DTLVardef@145c465org.highwire.dtl.DTLVardef@160c8aborg.highwire.dtl.DTLVardef@1165b76org.highwire.dtl.DTLVardef@ced5e0_HPS_FORMAT_FIGEXP M_FIG C_FIG

cell biology↗

Reconstructing biologically coherent cellular profiles from imaging-based spatial transcriptomics

In imaging-based spatial transcriptomics, transcript-to-cell assignment shapes downstream biological interpretation including cell typing, ligand-receptor inference, and niche characterization. However, two-dimensional segmentation of volumetric tissue often yields mixed cellular profiles, while cells without detected nuclei are missed entirely, distorting the aforementioned downstream analyses. We present TRACER, which refines cellular representations in imaging-based transcriptomics by leveraging gene-gene coherence and spatial co-localization of transcripts observed directly in the data, without requiring external annotations or reference atlases. TRACER resolves mixed cellular profiles and reconstructs partial cells whose nuclei are not detected, enabling more complete representation of cells within the tissue section. We also introduce coherence-based metrics that quantify transcriptional purity and conflict, enabling platform-agnostic benchmarking of segmentation quality. Across diverse platforms, tissues, and segmentation methodologies, TRACER consistently and reproducibly improves the coherence of cellular profiles and the quality of downstream analyses.

systems biology↗

Deep Learning Enabled 3D Multi-Omic Analysis Reveals Molecular Signatures of Heterogeneous Response to Chemotherapy in Pancreatic Cancer

Resistance to systemic therapy is a major unmet challenge in pancreatic cancer. To identify potential mechanisms of resistance, we developed a novel 3D pipeline in clinical samples that uses deep learning to classify sensitive and persistent tumor cell populations based on morphological features, enabling subsequent molecular characterization of intratumoral heterogeneity. We applied this automated 3D pipeline to a cohort of human pancreatic cancer samples treated with neoadjuvant chemotherapy, identifying heterogeneity in response to therapy both between and within tumors. Application of spatial proteomics to these sensitive and persistent regions identified enhanced epithelial-to-mesenchymal transition and non-classical cell states in persistent cells, confirming our morphological classification. Integration of spatial transcriptomics in multiple pancreatic cancer cohorts associated fibroblast-cancer crosstalk via syndecans with resistance to cytotoxic therapy. Our validated 3D multi-omic pipeline is now poised for application to clinical trials, enabling discovery of resistance mechanisms and design of new therapeutic combinations to circumvent resistance. Statement of significanceWe developed a novel 3D multi-omic pipeline to identify mechanisms of resistance to chemotherapy in clinical samples. This approach associated fibroblast-cancer crosstalk via syndecans with resistance to cytotoxic therapy and is poised for broader application in neoadjuvant clinical trials.

cancer biology↗

Multicellular signaling and partial recovery define reverse cardiac remodeling

Heart failure results from maladaptive multicellular remodeling triggered by sustained biomechanical stress. Although mechanical unloading can promote reverse remodeling, recovery is frequently incomplete and its mechanistic basis remains unclear. Using a reversible murine pressure-overload model combined with bulk and single-nucleus transcriptomics, we demonstrate that reverse remodeling represents an actively maintained yet constrained multicellular state. Unloading improved cardiac function and partially restored extracellular matrix and metabolic programs, whereas inflammatory and mitochondrial dysfunction signatures persisted. Cardiomyocytes and endothelial cells largely re-established homeostatic transcriptional states, while fibroblasts retained activated programs that dominated residual pathology. Multicellular factor analysis delineated a reversible metabolic stress program and a persistent inflammatory-mitochondrial program coordinated across cardiac cell types. Cell-cell communication analysis identified lymphatic endothelial cells as key instructive regulators of recovery. Notably, lymphatic-derived Reelin directly suppressed pathological fetal gene activation in murine and human cardiomyocytes, uncovering a previously unrecognized lymphoangiocrine mechanism that constrains myocardial recovery in chronic heart failure.

molecular biology↗

Automation workflow for high-throughput arrayed plasmid DNA preparation and quantification.

High-throughput generation of arrayed plasmid DNA library using commercially available miniprep kits remains labor-intensive and costly. The yield and quality of plasmid preparations directly affect downstream applications, including arrayed viral library production and CRISPR library screening. Insufficient plasmid yield or DNA concentration often requires repeated preparations or additional DNA concentration steps to obtain adequate quantities. Similarly, higher variations in yield or quality across wells or plates can render an entire library unsuitable for subsequent experiments. To increase productivity and mitigate human intervention and errors, the present study established an automated workflow for high-throughput plasmid DNA preparation and quantification. The workflow was carried out by the Biomek i7 Hybrid automated workstation, synergizing a robotic liquid handler and multiple peripheral instruments to produce and measure plasmid DNA in a 96-well plate format. Bacterial competent cells were alkaline lysed and plasmid DNA was purified using magnetic beads, followed by quantification with the PicoGreen assay. The PicoGreen assay reported median and average yields of approximately 9.5 and 10 {micro}g per sample, respectively, which are equivalent to 7.6 and 8 {micro}g/mL of bacterial culture. Plasmid DNA concentrations measured by the PicoFluor fluorometer were consistently lower than those obtained using the NanoDrop UV spectrophotometer. The comparison demonstrated robust positive correlation between PicoGreen assay and NanoDrop measurements (R2 > 0.8). Among 480 plasmid DNA samples, average and median yields measured by the NanoDrop reached approximately 24 and 25 {micro}g per sample per well, corresponding to 19 and 20 {micro}g/mL of bacterial culture. Over 98% of samples exceeded the high-yield threshold of 10 {micro}g/mL of culture, with high plasmid quality validated through DNA gel electrophoresis. Collectively, this study demonstrated a robust, scalable, and cost-effective automation platform for high throughput arrayed plasmid library generation and quantification.

molecular biology↗

MIMYR: Generative modeling of missing tissue in spatial transcriptomics

Spatial transcriptomics enables the study of how gene expression is organized across tissues, revealing how cells interact within their native microenvironments in health and disease. However, tissue damage during sectioning and the allocation of intermediate slices to other assays often result in regions or entire planes missing from the data, limiting downstream analysis. Here, we introduce MO_SCPLOWIMYRC_SCPLOW, a generative framework for reconstructing realistic spatial transcriptomics data in unmeasured tissue regions. MO_SCPLOWIMYRC_SCPLOW addresses this challenge through three coupled components: predicting cell locations via guided diffusion, assigning cell types through supervised classification, and generating gene expression profiles with a transformer conditioned on spatial and cellular context. MO_SCPLOWIMYRC_SCPLOW accurately reconstructs held-out regions in mouse brain data and generalizes across experimental conditions, including variations in gene panels and slicing orientations. After finetuning on limited Alzheimers disease data, MO_SCPLOWIMYRC_SCPLOW captures disease-associated transcriptional changes in unmeasured brain regions. By enabling high-fidelity spatial imputation from limited training data, MO_SCPLOWIMYRC_SCPLOW extends the utility of spatial transcriptomics, allowing researchers to recover unmeasured tissue states and deepen investigations into tissue spatial organization and dynamics.

bioinformatics↗

TRIM24 preserves cardiomyocyte immune quiescence by repressing interferon/STAT signaling

Innate immune activation in cardiomyocytes is a key driver of inflammatory heart disease and heart failure progression, yet the mechanisms by which cardiomyocytes maintain transcriptional immune quiescence remain poorly understood. TRIM24, a multidomain chromatin reader implicated in cancer and inflammation, has not been previously studied in the heart. Here, we investigated whether TRIM24 regulates interferon/STAT-driven inflammatory programs and paracrine signaling in cardiomyocytes. Single-nucleus RNA sequencing revealed a pronounced downregulation of TRIM24 specifically in cardiomyocytes from human ischemic cardiomyopathy, a change not detected by bulk RNA-sequencing in either human or mouse myocardial infarction samples, likely due to masking by non-cardiomyocyte cell populations. Fractionated protein analysis further demonstrated that TRIM24 is enriched in cardiomyocyte nuclei. Functional studies in neonatal rat ventricular cardiomyocytes showed that TRIM24 represses interferon-stimulated and STAT-dependent genes, including Mx1, Irf7, and Ifit3. ChIP-Seq revealed TRIM24 occupancy at STAT-bound regulatory regions, suggesting cooperative suppression of inflammatory gene networks. Mechanistically, TRIM24 decreased Stat1a/b and Stat3 transcription, reduced protein abundance, and inhibited phosphorylation independently of proteasomal degradation; these effects were partially reversible by bromodomain inhibition. Functionally, TRIM24 overexpression dampened paracrine macrophage recruitment, whereas TRIM24 depletion amplified it. Collectively, these findings identify TRIM24 as a cardiomyocyte-enriched chromatin regulator that restrains STAT1/3 signaling and suppresses paracrine inflammatory activation. TRIM24 acts as a transcriptional safeguard of immune quiescence in the heart and represents a potential therapeutic target for limiting cardiac inflammation.

molecular biology↗

Quantitative Calibration of a Spatial QSP Model Identifies Fibroblast Impact on HCC Immunotherapy

AbstractComputational models are increasingly used to predict treatment response and optimize cancer therapy strategies. Among these, quantitative systems pharmacology (QSP) models mechanistically simulate tumor progression and pharmacological interventions, enabling virtual clinical trials, model-informed drug development, and biomarker identification. Coupling QSP with an agent-based model yields a spatial QSP (spQSP) platform that captures tissue-level spatial organization of the tumor microenvironment (TME). However, parameterizing such models to represent tumor biology remains an open problem. In this study, we developed a calibration framework using the Approximate Bayesian Computation - Sequential Monte Carlo (ABC-SMC) approach to calibrate the spQSP model with a combination of clinical and spatial molecular data, reflecting the TME characteristics of human tumors. This calibration framework matches tumor architectures between spQSP model predictions and patient spatial molecular data by fitting statistical summaries of cellular neighborhoods. We demonstrate that model calibration using CODEX data from untreated HCC patients enables prediction of TME spatial molecular states in an independent cohort receiving immune-checkpoint inhibitor (ICI) and tyrosine kinase inhibitor (TKI) combination therapy. Finally, we identify spatial and non-spatial pretreatment biomarkers and assess their predictive power for therapeutic response. This workflow demonstrates how integrating spatial-omics with multiscale mechanistic models enables quantitative calibration, biological insight, and in silico biomarker discovery, providing a framework for personalized cancer therapy across tumor types. SignificanceDigital twins and computational models are increasingly used to simulate disease and guide therapy, but they often struggle to capture the immense complexity driving the spatiotemporal evolution of the TME. The challenge is compounded by clinical sample limitations, which typically provide measurements from only static snapshots of the TME for parameter estimation. We demonstrate how mechanistic modeling frameworks can overcome this limitation by enabling inference of spatiotemporal model parameters from static spatial data - an intractable task for purely data-driven approaches. Ultimately, our work presents a workflow that integrates spatial-omics with multiscale mechanistic models, enabling quantitative calibration, deeper biological insight, and in silico biomarker discovery.

bioinformatics↗

ZEB1 Is a Key Regulator of Cardiomyocyte Structure and Function

BackgroundOur previous work identified the transcription factor "Zinc Finger E-Box Binding Homeobox 1" (ZEB1) as a downstream effector of Cytoplasmic Polyadenylation Element Binding Protein 4 (CPEB4), an RNA-binding protein responsive to cardiac stress. While ZEB1 is known for its role in cancer metastasis and epithelial-to-mesenchymal transition (EMT), its function in cardiomyocytes is not well understood. Based on previous findings, we hypothesize that ZEB1 is essential for maintaining the structural integrity and mitochondrial function of cardiomyocytes. MethodsAAV9-Zeb1 was used for the overexpression of Zeb1. Using a myosin heavy chain alpha (MHC) Cre system, we created a Zeb1 conditional knockout mouse. To evaluate cardiac function and structure, we used echocardiography, electron microscopy, immunohistochemistry. We identified differentially expressed genes following Zeb1 deletion using RNA-seq and determined direct Zeb1 target genes by integrating this transcriptome data with a Zeb1 ChIP-seq dataset. ResultsZEB1 deletion leads to sarcomere damage, mitochondrial dysfunction, and dedifferentiation, with more pronounced effects in females. Overexpression promotes hypertrophic remodeling. Echocardiographic analysis showed progressive systolic dysfunction, and histology revealed sarcomeric disarray, again especially in females. A tamoxifen-inducible ZEB1 knockout mouse model only confirmed ZEB1s crucial role in fully differentiated cardiomyocytes in female mice. Integrated analysis of RNA-seq and ChIP-seq revealed that Zeb1 directly regulated mitochondrial genes, thereby playing a critical role cardiomyocyte energy supply and having secondary effects on cardiac structure and function. ConclusionsZEB1 is critical for cardiomyocyte homeostasis, and maintaining its function is necessary for normal cardiac performance and structure.

molecular biology↗